Hot Topics on Cholangiocarcinoma at the 2023 Cholangiocarcinoma Foundation Annual Conference

Videos — April 11, 2023

Featuring:

Melinda Bachini
Director of Advocacy
Cholangiocarcinoma Foundation
Billings, MT
Juan W. Valle, MB ChB, MSc, FRCP
Professor and Honorary Consultant
Medical Oncology
Manchester Academic Health Sciences
Centre Institute of Cancer Studies
University of Manchester
Lead, The Christie European
Neuroendocrine Tumour Society
Centre of Excellence
Manchester, UK

On April 14, 2023, we presented an overview of key abstracts on cholangiocarcinoma (CCA) presented at the 2023 Cholangiocarcinoma Foundation Annual Conference. In addition, we provided our perspectives on the impact of the data on the management of patients with CCA.

Related Items

Artificial Intelligence and Clinical Experience: Shaping the Future of CCA Care
June/July 2026, Vol 7, No 2
A look at how the synergy between artificial intelligence and clinical expertise is potentially shaping the outlook of cholangiocarcinoma care.
Cholangiocarcinoma Clinical Trials: Debunking Myths, Uncovering Facts, and Exploring Opportunities
June/July 2026, Vol 7, No 2
Uncover how clinical trials are transforming cholangiocarcinoma treatment, offering patients personalized therapies, expanded options, and new hope for the future.
The Changing Paradigm of Cellular Immunotherapy in Cholangiocarcinoma
June/July 2026, Vol 7, No 2
Explore how cellular immunotherapy, from tumor-infiltrating lymphocytes to circulating tumor-reactive T cells, is expanding the treatment landscape for cholangiocarcinoma.
Antibody-Drug Conjugates in Biliary Tract Cancers
June/July 2026, Vol 7, No 2
Antibody-drug conjugates show potential in cancer treatment and may signal new possibilities for biliary tract cancer patients in this significant exploration.
Advancing Hepatic Arterial Infusion Pump Chemotherapy for Intrahepatic Cholangiocarcinoma: Boosting Survival and Quality of Life
June/July 2026, Vol 7, No 2
Hepatic arterial infusion pump chemotherapy is transforming treatment for intrahepatic cholangiocarcinoma by improving survival rates and enhancing quality of life.
Exploring Protein Arginine Methyltransferases as Promising Therapeutic Targets in Cholangiocarcinoma
June/July 2026, Vol 7, No 2
Targeting protein arginine methyltransferases offers a promising new approach to combat cholangiocarcinoma by suppressing tumor growth and enhancing immune responses.
Advancing CAR T Cell Therapy for Cholangiocarcinoma
June/July 2026, Vol 7, No 2
Discover how emergent research on CAR T-cell therapy is paving the way for new possibilities in cholangiocarcinoma treatment.
Overcoming Therapeutic Resistance in Cholangiocarcinoma: Exploring Combination Strategies and Adaptive Lineage States
June/July 2026, Vol 7, No 2
Cutting-edge research on therapeutic resistance and innovative combination strategies is adding new possibilities to the fight against cholangiocarcinoma.
Biomarker Discovery and Early Detection in CCA
June 2025, Vol 6, No 2
Experts unveiled a roadmap for translating cutting-edge biomarkers into clinical practice, paving the way for improved early detection and personalized care in high-risk populations with cholangiocarcinoma (CCA).
Translational Science and Discovery in CCA
June 2025, Vol 6, No 2
Leading experts explored groundbreaking advancements in tumor microenvironments, biomarker validation, and innovative therapies, paving the way for transformative precision medicine in cholangiocarcinoma (CCA) care.

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

Profession or Role
Primary Specialty or Disease State